Cargando…
Targeting CAR to the Peptide-MHC Complex Reveals Distinct Signaling Compared to That of TCR in a Jurkat T Cell Model
SIMPLE SUMMARY: Chimeric antigen receptors (CARs) redirect T cells without the need for major histocompatibility complex (MHC) restriction. CARs are designed based on T cell receptor (TCR) signaling and the recognition specificities of antibodies. This technology has achieved great clinical success...
Autores principales: | Wu, Ling, Brzostek, Joanna, Sankaran, Shvetha, Wei, Qianru, Yap, Jiawei, Tan, Triscilla Y.Y., Lai, Junyun, MacAry, Paul A., Gascoigne, Nicholas R. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922477/ https://www.ncbi.nlm.nih.gov/pubmed/33670734 http://dx.doi.org/10.3390/cancers13040867 |
Ejemplares similares
-
Nonstimulatory peptide–MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling
por: Zhao, Xiang, et al.
Publicado: (2018) -
CD28-CAR-T cell activation through FYN kinase signaling rather than LCK enhances therapeutic performance
por: Wu, Ling, et al.
Publicado: (2023) -
Lck bound to coreceptor is less active than free Lck
por: Wei, Qianru, et al.
Publicado: (2020) -
Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide–MHC
por: Hoerter, John A.H., et al.
Publicado: (2013) -
Themis-associated phosphatase activity controls signaling in T cell development
por: Mehta, Monika, et al.
Publicado: (2018)